Alternative Structures of α-Synuclein.
A-synuclein
amyloid
fibril
hydrophobicity
misfolding
protein folding
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
30 Jan 2020
30 Jan 2020
Historique:
received:
19
12
2019
revised:
08
01
2020
accepted:
17
01
2020
entrez:
6
2
2020
pubmed:
6
2
2020
medline:
21
11
2020
Statut:
epublish
Résumé
The object of our analysis is the structure of alpha-synuclein (ASyn), which, under in vivo conditions, associates with presynaptic vesicles. Misfolding of ASyn is known to be implicated in Parkinson's disease. The availability of structural information for both the micelle-bound and amyloid form of ASyn enables us to speculate on the specific mechanism of amyloid transformation. This analysis is all the more interesting given the fact that-Unlike in Aβ(1-42) amyloids-only the central fragment (30-100) of ASyn has a fibrillar structure, whereas, its N- and C-terminal fragments (1-30 and 100-140, respectively) are described as random coils. Our work addresses the following question: Can the ASyn chain-as well as the aforementioned individual fragments-adopt globular conformations? In order to provide an answer, we subjected the corresponding sequences to simulations carried out using Robetta and I-Tasser, both of which are regarded as accurate protein structure predictors. In addition, we also applied the fuzzy oil drop (FOD) model, which, in addition to optimizing the protein's internal free energy, acknowledges the presence of an external force field contributed by the aqueous solvent. This field directs hydrophobic residues to congregate near the center of the protein body while exposing hydrophilic residues on its surface. Comparative analysis of the obtained models suggests that fragments which do not participate in forming the amyloid fibril (i.e., 1-30 and 100-140) can indeed attain globular conformations. We also explain the influence of mutations observed in vivo upon the susceptibility of ASyn to undergo amyloid transformation. In particular, the 30-100 fragment (which adopts a fibrillar structure in PDB) is not predicted to produce a centralized hydrophobic core by any of the applied toolkits (Robetta, I-Tasser, and FOD). This means that in order to minimize the entropically disadvantageous contact between hydrophobic residues and the polar solvent, ASyn adopts the form of a ribbonlike micelle (rather than a spherical one). In other words, the ribbonlike micelle represents a synergy between the conformational preferences of the protein chain and the influence of its environment.
Identifiants
pubmed: 32019169
pii: molecules25030600
doi: 10.3390/molecules25030600
pmc: PMC7038196
pii:
doi:
Substances chimiques
Amyloid
0
Peptide Fragments
0
SNCA protein, human
0
alpha-Synuclein
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Uniwersytet Jagielloński Collegium Medicum
ID : N41/DBS/000211
Références
Acta Neuropathol. 2017 Dec;134(6):819-838
pubmed: 28803412
Int Rev Cell Mol Biol. 2017;329:79-143
pubmed: 28109332
J Biol Chem. 2005 Mar 11;280(10):9595-603
pubmed: 15615727
Nucleic Acids Res. 2000 Jan 1;28(1):235-42
pubmed: 10592235
FEBS Lett. 2004 Oct 22;576(3):363-8
pubmed: 15498564
Neurosci Lett. 2018 Apr 13;672:140-144
pubmed: 29203207
Biochim Biophys Acta. 2000 Jul 26;1502(1):16-30
pubmed: 10899428
Proteins. 2014 Feb;82 Suppl 2:1-6
pubmed: 24344053
Int J Mol Sci. 2018 Sep 25;19(10):
pubmed: 30257460
J Mol Graph Model. 2019 Mar;87:227-239
pubmed: 30580160
J Mol Biol. 1976 Jun 14;104(1):59-107
pubmed: 957439
J Biol Chem. 2018 Jan 19;293(3):767-776
pubmed: 29191831
Cell. 2005 Nov 4;123(3):359-61
pubmed: 16269324
J Comput Chem. 2005 Dec;26(16):1701-18
pubmed: 16211538
J Am Chem Soc. 2016 Aug 3;138(30):9663-74
pubmed: 27355699
Nucleic Acids Res. 2004 Jul 1;32(Web Server issue):W526-31
pubmed: 15215442
Nature. 2017 Jul 13;547(7662):185-190
pubmed: 28678775
Biophys Rev. 2017 Oct;9(5):501-515
pubmed: 28905328
Nat Struct Mol Biol. 2015 Jun;22(6):499-505
pubmed: 25938662
Structure. 2015 Jan 6;23(1):216-227
pubmed: 25543257
Nat Protoc. 2010 Apr;5(4):725-38
pubmed: 20360767
Neuron. 2018 Jan 3;97(1):3-4
pubmed: 29301103
Neuron. 1995 Feb;14(2):467-75
pubmed: 7857654
Phys Chem Chem Phys. 2018 Feb 7;20(6):4502-4512
pubmed: 29372732
Angew Chem Int Ed Engl. 2015 Jan 2;54(1):331-5
pubmed: 25395337
Neuron. 2010 Jan 14;65(1):66-79
pubmed: 20152114
Nat Struct Mol Biol. 2016 May;23(5):409-15
pubmed: 27018801
In Silico Biol. 2006;6(1-2):15-22
pubmed: 16789910
Structure. 2014 Feb 4;22(2):238-49
pubmed: 24361273
Cell Tissue Res. 2018 Jul;373(1):213-220
pubmed: 29116402
Science. 2010 Sep 24;329(5999):1663-7
pubmed: 20798282
Neurochem Res. 2017 Dec;42(12):3362-3371
pubmed: 28828740
Nat Commun. 2014 May 29;5:3827
pubmed: 24871041
Acta Biochim Pol. 2019 Nov 20;66(4):451-458
pubmed: 31747510
ACS Chem Neurosci. 2017 Dec 20;8(12):2722-2733
pubmed: 28872299
J Vis Exp. 2017 Aug 13;(126):
pubmed: 28829427
Neuromolecular Med. 2002;2(2):115-29
pubmed: 12428807
Molecules. 2019 Dec 03;24(23):
pubmed: 31816829
Protein Sci. 2018 Jan;27(1):129-134
pubmed: 28875543
Acta Biochim Pol. 2018 Nov 21;65(4):595-604
pubmed: 30465553
J Biol Chem. 2011 Oct 14;286(41):35863-73
pubmed: 21849493
Science. 2017 Dec 15;358(6369):1440-1443
pubmed: 29242346
Biochim Biophys Acta Biomembr. 2018 Mar;1860(3):757-766
pubmed: 29273335